Jose Luis D. E.
- Country
- Spain
- Department
- Urology
Research Overview
Data & Insights
Has run more than one trial at 0 of 2 partner sites.
Specializations
Prostate Cancer
Investigation of advanced disease forms, including castration‑resistant and hormone‑sensitive variants.
- Metastatic castration‑resistant prostate cancer
- High‑risk localized prostate cancer
- Hormone‑naive prostate cancer
- PSMA‑positive prostate cancer
Focus on therapeutic strategies for disease progression and recurrence.
Bladder Cancer
Research on both non‑muscle invasive and muscle‑invasive disease of the urinary bladder.
- Non‑muscle invasive bladder cancer
- Muscle‑invasive bladder cancer
- BCG‑unresponsive carcinoma in situ
- Electromotive drug administration with mitomycin C
Emphasis on novel delivery methods and bladder‑preserving approaches.
Renal Cell Carcinoma
Studies addressing clear cell and non‑clear cell subtypes of kidney malignancies.
- Advanced clear cell renal cell carcinoma
- Metastatic non‑clear cell renal cell carcinoma
- Intermediate‑risk renal cell carcinoma
- Combination immunotherapy for renal cell carcinoma
Targeted at improving outcomes in metastatic settings.
Upper Tract Urothelial Carcinoma
Clinical focus on urothelial tumors of the renal pelvis and ureter.
- Upper tract urothelial carcinoma
- Low‑grade upper tract urothelial cancer
- Neoadjuvant cisplatin‑based therapy for UTUC
- Adjuvant chemotherapy eligibility in UTUC
Seeks to define optimal peri‑operative management.
Metastatic Solid Tumors (Broad)
Participation in trials encompassing diverse metastatic solid malignancies beyond the urologic tract.
- Metastatic solid tumors with HER2 alterations
- KRAS‑mutant non‑small cell lung cancer
- Advanced gastrointestinal stromal tumor
- Metastatic melanoma
Integrates cross‑tumor biomarker‑driven therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.